LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

thanks for the compliment Tabby .... just cross with myself rather than suffering

I fear that the sp will trickle down during the day and the initial move up will stop....too late for me to get in...

You are not alone cynic! I hesitated for a second over the sell button, that was long enough for the sp to slump way below my "shall I shan't I?" threshold. Sold a few, at a loss, to cover another trade which could have waited until today when I would have sold at a profit! Still, although I watched a stonking profit on the rest of my holding, now only 65k, dribble away, I am surprisingly very happy to hold. I like Sirco, I like the possible "transformational" deals that could come from Fruitflow. Let's just hope that PXS can be good enough themselves to make the right contacts. At least, as far as I am aware, Coca Cola are still interested.

better than SEO m8 ..... what a cruel chap i am!

Can't argue with that cynic! Having said that I believe SEO will be around for a long time now they have got back to the basics that they are good at. I doubt they will ever again get over-excited about a new product without fully testing it and comparing it with others. But then again, never say never! :o)

I've missed my chance on this today...there must be people out there that have made a packet on these ups and downs...

relative calm, though still an awful lot of traffic ...... about 3m being bid against 1.8m offered ..... quite a lot being offered at 10p

so there we have it - a sensible calm 10% rise and 30m buys to 21m sells.

Wonderful....:))

looks quite solid around this level, though there were certainly a lot on offer at 10.00 ..... tomorrow being friday may bring more selling, or conversely strength if there is much of a build up in shorts (or even g-strings)

OH YES!!

a build up in g-strings....the mind boggles

2.5p and the subscription is up and running.....

2.5p and I thought it would be 6p.....it's even worse...

20% extra shares, which is a dilution of 1.25p or thereabouts (9p - 2.5p) which gives a 'fair' price of about 7.75p. Whether that happens is another matter!!

still strong buying going on because the underlying potential of this company far outweighs the short term dilution.

Summary

The offer is in 3 parts

part 1 is to the institutional/high net worth individuals mentioned yesterday. They will share 40,969,390 shares at 2.5p raising 1.024m for PXS. these shares will be added to the market on wed 30th sept.

part 2. due to restrictions in company articles on issuing new shares a meeting and resolution needs to be passed by shareholders so these same investors can get another 159,030,610 shares at 2.5p raising 3.976m for PXS. thiese will be added to the market between 16th and 30th october.

part 3 is for all existing shareholders and subject to shareholder approval. Another 1.5m will be raised meaning approx. 60,000,000 shares at 2.5p. this will be done as an open offer rather than a rights issue since it is deemed simpler/faster. (you should be able to subscribe to as many as you want irrespective of your holding)

This last part does not seem to be confirmed and does not appear to be added into the other figures - this is the part that adds to the confusion. All other figures/comments refer only to part 1 and 2. The rns in total lists a potential 6.5m and 260,000,000 shares - closer to 24%.

The fact that it is at 2.5p is going to drag on the sp.....very low price indeed.

The shares are still being mopped up.... but are we getting into another SEO??

nomad you are a pratt where in the rns at any point does it mention institutions? parts 1/2 are for ordinary shareholders